Rhythm Biosciences Ltd (ASX:RHY) Completes Genetype Integration
Rhythm Biosciences (ASX:RHY) completes Genetype integration, enhancing commercial operations for geneType™ and ColoSTAT® products.
The Hub of Australian Finance News
Rhythm Biosciences (ASX:RHY) completes Genetype integration, enhancing commercial operations for geneType™ and ColoSTAT® products.
Beamtree Holdings Limited (ASX:BMT) appoints Marek Stepniak as new CEO to drive global growth and innovation in the healthcare sector.
BlueBet Holdings Ltd (ASX:BBT) requests a trading halt pending a material acquisition and equity capital raising announcement.
Micro-X Limited (ASX:MX1) has voluntarily suspended trading of its shares pending an equity raising announcement.
Briscoe Group Limited (ASX:BGP) reports a 0.96% Q4 sales increase and expects full-year NPAT in line with guidance.
Rapid Lithium Ltd (ASX:RLL) announces the results of its partially underwritten Entitlement Offer, detailing share and option allocations and future placement plans.
Black Canyon Limited (ASX:BCA) reports significant KR2 infill drilling results, enhancing mineral resource potential and project economics.
SEEK Limited (ASX:SEK) terminates its acquisition scheme for Xref Limited after receiving only 67.60% shareholder support.
Tanami Gold NL (ASX:TAM) announces high-grade assay results from the Jims Gold Mine drilling program, highlighting significant intercepts.
OncoSil Medical (ASX:OSL) expands its presence in Germany with a 43% increase in hospitals authorized to negotiate funding for its innovative OncoSil™ device.